Grifols Cash from Operations (TTM) Trends

Grifols SA (GRFS)

6.28 -0.26 (-3.98%) USD | NASDAQ | Apr 19, 16:00

6.29 +0.01 (+0.16%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
June 30, 2021	1.081B
March 31, 2021	1.366B
December 31, 2020	1.268B
September 30, 2020	1.256B
June 30, 2020	1.069B
March 31, 2020	943.71M
December 31, 2019	636.92M
September 30, 2019	772.66M
June 30, 2019	736.74M
March 31, 2019	566.36M
December 31, 2018	870.76M
September 30, 2018	757.78M
June 30, 2018	834.30M
March 31, 2018	912.30M
December 31, 2017	953.28M
September 30, 2017	866.95M
June 30, 2017	840.36M
March 31, 2017	702.87M
December 31, 2016	612.35M
September 30, 2016	759.91M

Date	Value
June 30, 2016	728.61M
March 31, 2016	850.11M
December 31, 2015	824.26M
September 30, 2015	913.14M
June 30, 2015	1.037B
March 31, 2015	1.169B
December 31, 2014	1.302B
September 30, 2014	1.171B
June 30, 2014	969.51M
March 31, 2014	835.36M
December 31, 2013	786.24M
September 30, 2013	701.44M
June 30, 2013	742.56M
March 31, 2013	669.29M
December 31, 2012	651.97M
September 30, 2012	656.19M
June 30, 2012	558.48M
March 31, 2012	352.00M
December 31, 2011	307.07M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

636.92M

Minimum

Dec 2019

1.366B

Maximum

Mar 2021

1.014B

Average

1.069B

Median

Jun 2020

Cash from Operations (TTM) Benchmarks

DBV Technologies SA	-79.65M
Adaptimmune Therapeutics PLC	-140.88M
Biodexa Pharmaceuticals Plc	-8.984M
NuCana PLC	-32.90M
Autolus Therapeutics PLC	-145.59M